Background/Aims: Dexamethasone (Dex)-induced spontaneous tendon rupture and decreased self-repair capability is very common in clinical practice. The metaplasia of adipose tissue in the ruptured tendon indicates that Dex may induce tendon stem cells (TSCs) to differentiate into adipocytes, but the mechanism remains unclear. In the present study, we used in vitro methods to investigate the effects of Dex on rat TSC differentiation and the molecular mechanisms underlying this process. Methods: First, we used qPCR and Western blotting to detect the expression of the adipogenic differentiation markers aP2 and C/EBPα after treating the TSCs with Dex. Oil red staining was used to confirm that high concentration Dex promoted adipogenic differentiation of rat TSCs. Next, we used qPCR and Western blotting to detect the effect of a high concentration of dexamethasone on molecules related to the canonical WNT/β-catenin pathway in TSCs. Results: Treating rat TSCs with Dex promoted the synthesis of the inhibitory molecule dickkopf1 (DKK1) at the mRNA and protein levels. Western blotting results further showed that Dex downregulated the cellular signaling molecule phosphorylated glycogen synthase kinase-3β (P-GSK-3β (ser9)), upregulated P-GSK-3β (tyr216), and downregulated the pivotal signaling molecule β-catenin. Furthermore, DKK1 knockdown attenuated Dex-induced inhibition of the canonical WNT/β-catenin pathway and of the adipogenic differentiation of TSCs. Lithium chloride (LiCl, a GSK-3β inhibitor) reduced Dexinduced inhibition of the classical WNT/β-catenin pathway in TSCs and of the differentiation of TSCs to adipocytes. Conclusion: In conclusion, by upregulating DKK1 expression, reducing the level of P-GSK-3β (ser9), and increasing the level of P-GSK-3β (tyr216), Dex causes the degradation of β-catenin, the central molecule of the classical WNT pathway, thereby inducing rat TSCs to differentiate into adipocytes.
Introduction
Due to its anti-inflammatory and immunosuppressive effects, glucocorticoid has been widely used in the treatment of tendon disease and autoimmune diseases. Local injection of glucocorticoid is effective for reducing inflammation and improving pain symptoms in the treatment of early tendon disease. Long-term local injection of glucocorticoid to treat tendon disease or systemic use to treat tendon rupture caused by autoimmune disease is very common in clinical practice [1] [2] [3] . Clinical investigation has shown that glucocorticoidinduced tendon rupture is accompanied by adipose metaplasia [4, 5] . Compared with tendon rupture caused by trauma, glucocorticoid-induced tendon rupture has a poor surgical repair rate, and it is prone to repeated rupture over the long term, indicating that glucocorticoid reduces the self-repair capability of the tendon. The irreplaceability of glucocorticoid in clinical practice and the challenge of the clinical treatment of glucocorticoid-induced tendon rupture make it necessary to investigate the mechanisms underlying glucocorticoid-induced tendon rupture, the adipose metaplasia, and the reduced self-repair capability so that an intervention strategy targeting the side effects of glucocorticoid on tendon can be identified.
It is well known that the maintenance and repair of adult tissues relies on small populations of resident stem cells [6, 7] . Recently, a group of adult stem cells has been found in human, mouse [8] and rat tendon [9] ; this group of cells was therefore named tendon stem cells (TSCs). Tendons are maintained in a dynamic balance between microdamage and self-repair [10] . TSCs have a strong ability to proliferate and to differentiate into tendon cells, and such differentiation is very important for the self-renewal and repair of tendon [11, 12] . However, under abnormal conditions, TSCs can also differentiate into cells of other mesodermal tissues, such as bone, cartilage, and adipocytes [8, 9] . When TSCs differentiate into non-tendon cells, the self-repair ability of tendon is reduced [11, 13] . Our previous studies found that Dex inhibits TSC differentiation into tendon cells by down regulating scleraxis. Zhang found that Dex treatment of human TSCs increases the levels of PPARγ, a marker of adipogenic differentiation. When Dex-treated TSCs were implanted subcutaneously into rats, adipose tissue formation was observed through oil red staining [13] . The Dex-induced inhibition of TSC differentiation into tendon cells and promotion of differentiation into adipocytes may be important means by which Dex causes spontaneous tendon rupture and impairs the self-repair function. However, the underlying molecular mechanism has not been reported.
The differentiation of stem cells into adipocytes is mainly regulated by BMPs or the classical WNT signaling pathway [14] . The Wnt/β-catenin signaling pathway plays an important role in regulating adipogenesis. Under normal culture conditions, the WNT signaling pathway and adipogenic pathway are reciprocally regulated [15] . Factors that inactivate the Wnt/β-catenin pathway, including DKK1, are known to promote adipogenesis in vitro. In the present study, we demonstrate that by promoting DKK1 expression, reducing the level of P-GSK-3β (ser9), and increasing the level of P-GSK-3β (tyr216), Dex causes the degradation of β-catenin, the central molecule of the canonical WNT pathway, thereby promoting TSCs to differentiate into adipocytes.
in PBS followed by centrifugation at 300 g for 5 min and then resuspended in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA, USA) containing 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine (all from Invitrogen, Carlsbad, CA, USA). The isolated cells were diluted to different cell densities and cultured at 37°C in 5% CO 2 to form colonies. At day 2 after initial plating, the cells were washed twice with PBS to remove nonadherent cells. At day 7, the cells were trypsinized and mixed together as passage 0 (P0) cells [16] . Cells from passage 3 (P3) were used for subsequent experiments. TSCs were seeded onto 6-well plates for mRNA extraction, 10-cm-diameter petri dishes for protein extraction and coverslips in 24-well plates for oil red staining and immunostaining. Culture medium with or without 1 μM dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) dissolved in dimethyl sulfoxide (DMSO) and lithium chloride (LiCl) (Sigma-Aldrich, St. Louis, MO, USA) dissolved in distilled water was changed every 3 days throughout the experiments.
shRNA interference Cell transfection was performed when the cells reached 80% confluence. The shRNA knockdown plasmids for DKK1 were purchased from GenePharma (GenePharma, Shanghai, China). Transfection was performed using the Lipofectamine 2000 reagent (Invitrogen, CA, USA) in Opti-MEM (Invitrogen, CA, USA) according to the manufacturer's protocol. TSCs were transfected for 4 h, and the transfection mixture was replaced with culture medium.
qPCR
The mRNA expression levels of scleraxis, C/EBPα, aP2, DKK1 were determined using qPCR. Total RNA was extracted from cells using TRIzol reagent, according to the protocol provided by the manufacturer (Takara, Dalian, China). cDNA was synthesized from total RNA using a Superscript III first-strand synthesis kit (TaKaRa). qPCR was performed using a SYBR Green RT-PCR kit (TaKaRa) and an ABI Prism 7900 Sequence Detection System (PE Applied Biosystems, Foster City, CA, USA). Expression levels were calculated relative to the expression of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The primer sequences used in this research are listed in Table 1 .
Protein extraction and Western blotting
Cells were scraped and homogenized in lysis buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl) containing a mixture of proteinase inhibitors (Thermo Fisher Scientific Inc., Rockford, IL, USA). Protein concentrations were measured using a BCA protein assay kit (Thermo Fisher Scientific Inc., Rockford, IL, USA). Protein samples (30 μg/lane) were resolved by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. After blocking with 0.1% TBS-Tween containing 5% non-fat milk for 1 h at 20°C, membranes were incubated sequentially with primary and secondary antibodies. The following primary antibodies were used: anti-aP2 (Abcam), C/EBPα (Abcam), DKK1 (Abcam), Phospho-GSK-3α/β (ser21/9) (Cell Signaling, Danvers, MA, USA), Phospho-GSK-3α/β (tyr279/tyr216) (Abcam), anti-active β-catenin (Millipore, Billerica, MA, USA). The results were visualized and images captured using a LiCor Odyssey Table 1 . qPCR primers Imager (LI-COR Biosciences, Lincoln, NE, USA).
Immunostaining P3 TSCs were grown on glass coverslips, and cytospins or smear preparations were made. Cells were incubated with diluted anti-active β-catenin antibody (Millipore) in 5% BSA in PBS-Tween-20 (PBST) overnight at 4°C. Then, the cells were incubated with Alexa Fluor 546 donkey anti-rabbit IgG (1:500) (Invitrogen, San Diego, CA, USA) in 5% BSA for 1 h at room temperature in the dark. The samples were also incubated with 0.5 μg/ml DAPI (Beyotime, Shanghai, China) Oil red staining and HE staining Cultured TSCs were plated on cover slides in 24-well plates and treated with or without dexamethasone, DKK1 shRNA plasmid or LiCl in the culture medium for 21 days. Next, the cells were washed with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde and stained with Oil Red O. Adipocytes were photographed under a microscope at 400 × magnification. Human Achilles tendon specimens were obtained from patients in the Department of Orthopedic Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China, with written consent. Experiments were approved by the institutional ethics committee. Human Achilles tendon specimens from cases of tendon rupture caused by trauma or dexamethasone treatment were fixed with 4% paraformaldehyde. Five sections were cut at a thickness of 4 mm and stained with hematoxylin and eosin.
Statistical analysis Statistically significant differences were determined using Student's t-test or two-way analysis of variance. A P-value of ≤ 0.05 was considered significant. All values are presented as the means ± standard deviation (SD).
Results

Dex induces TSCs to differentiate into adipocytes
We studied the effects of different concentrations of Dex on TSC differentiation by examining the expression of tenogenic differentiation transcription factor scleraxis and the adipogenic differentiation transcription factor C/EBPα via qPCR. Rat TSCs were treated by different concentration of Dex for 3 days. Dex at 1 nM has no effect on the expression of either scleraxis or C/EBPα, Dex at 10 nM promoted scleraxis expression, and Dex at 100 nM of Dex had no effect on scleraxis expression, while Dex at the high concentration of 1 µM inhibited scleraxis expression. Dex at 10 nM inhibited C/EBPα expression, and the high concentrations of Dex, 100 nM and 1 µm, promoted C/EBPα expression (Fig. 1A-B) . 
First, we used HE staining to compare the histological differences between the Achilles tendon ruptured by acute trauma and the Achilles tendon ruptured by long-term systemic administration of Dex. Collagen fibers in the Achilles tendon ruptures caused by trauma were arranged in an orderly manner, whereas the collagen fibers in the Achilles tendon ruptures caused by Dex were arranged irregularly and were accompanied by adipose tissue metaplasia ( Fig. 2A) . It is well known that the cytosol of mature adipocytes contains lipid droplets. After TSCs were treated with 1 µM Dex for 21 days, the formation of lipid droplets in the cytosol was observed through oil red staining (Fig. 2B) . After TSCs were treated with Dex for 3 days, 5 days, 7 days and 14 days, qPCR showed increases in the adipogenic differentiation markers aP2 and C/EBPα. With time, aP2 and C/EBPα levels were gradually increased in both the control group and the experimental group (Fig. 2C, F) . Western blotting results showed that after treating TSCs with Dex, aP2 and C/EBPα protein expression levels also increased ( Fig.  2D-E, G-H) . Immunofluorescence assays of aP2-positive cells showed that after treatment of TSCs with Dex for 7 days, large numbers of aP2-positive cells had formed, and the cytosol of some of the positive cells contained lipid droplet-like structures (Fig. 2I) .
Dex inhibits the canonical WNT/β-catenin pathway
Dickkopf (Dkk) family members specifically inhibit canonical WNT signaling by binding as high-affinity antagonists to LRP co-receptors [17] . We treated TSCs with 1 µM Dex for 3, After TSCs were treated with Dex for 3, 5, 7, and 14 days, C/EBPα and aP2 expression levels were increased at both mRNA and protein levels. qPCR showed that C/EBPα and aP2 expression levels increased with longer exposure to Dex. Relative mRNA and protein expression levels were normalized to GAPDH. The data are presented as the means ± SD of three independent experiments. *: P < 0.05, **: P < 0.01, N = 3. (E) After treating TSCs with Dex for 7 days, aP2-positive cells were generated, and some of those cells contained cytosolic lipid droplet-like structures (white arrows point to aP2-positive cells 200 ×). N = 3.
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry 5, 7 and 14 days, and we found that Dex increased DKK1 mRNA and protein expression (Fig.  3A-C) . The canonical WNT signaling pathway converges on the transcriptional regulator β-catenin [18] . After GSK-3β is activated, it can form a degradation complex with β-catenin to promote β-catenin degradation. P-GSK-3β (ser9) is the inactive form of GSK-3β, while P-GSK-3β (tyr216) is the active form GSK-3β [19] . To study the effect of Dex on the canonical WNT pathway, TSCs were treated with 1 µM Dex for 3, 5, or 7 days. Through Western blotting, we found that with 3 days of Dex treatment, both P-GSK-3β (ser9) and P-GSK-3β (tyr216) showed little change, whereas with Dex treatment for 5 days or 7 days, P-GSK-3β (ser9) decreased, and P-GSK-3β (tyr216) increased (Fig. 4A-D) . When TSCs were treated with Dex for 3 days, β-catenin levels did not show a significant decrease, whereas with treatment for 5 days or 7 days, the expression of β-catenin decreased significantly (Fig. 4E-F) . Immunohistochemistry showed that treatment of TSCs with Dex for 7 days significantly decreased the expression of β-catenin in the cytoplasm and nucleus (Fig. 4G-H) .
DKK1 knockdown attenuated the inhibition of Dex on the canonical WNT pathway and induced adipogenic differentiation of TSCs
To investigate the role of DKK1 in the Dex-induced inhibition of the canonical WNT/β-catenin pathway in TSCs and the Dex-induced promotion of adipogenic differentiation of TSCs, we used an shRNA plasmid to knock down DKK1, and we examined the changes to the canonical WNT/β-catenin pathway in TSCs and the changes in adipogenic differentiation of TSCs after 5 days of interference. Western blotting showed that DKK1 interference attenuated the down regulation of Dex to P-GSK-3β (ser9) (Fig. 5A-B) and the up regulation of Dex to P-GSK-3β (tyr216) (Fig. 5C-D) . Meanwhile, DKK1 knockdown up regulated active β-catenin and attenuated the Dex-induced down regulation of active β-catenin (Fig. 5E-F) . qPCR and Western blotting showed that DKK1 knockdown attenuated the Dex-induced up regulation of aP2 and C/EBPα (Fig. 5G-J) . Immunofluorescence showed that DKK1 interference reduced between adipogenic and osteogenic differentiation of BMSCs, promoting the adipogenic differentiation of BMSCs, which plays an important role in the mechanism of Dex-induced osteoporosis [28] .
Many factors have been found to induce preadipocytes to differentiate into adipocytes, including insulin-like growth factor 1 (IGF1), glucocorticoid, and cyclic AMP (cAMP). The tendon disease tissue itself may have adipose tissue metaplasia. To verify that the adipose tissue in ruptured tendon is caused by Dex, rather than being a pathological variation of tendon disease itself, we compared ruptured tendon caused by the long-term systemic administration of Dex due to autoimmune disease with ruptured tendon caused by acute trauma. We found that there was adipose tissue metaplasia in the ruptured tendon caused by systemic administration of Dex. In in vitro cell culture experiments, although the routine adipogenic differentiation induction solution DIM contains insulin and phosphodiesterase inhibitor methylisobutylxanthine (IBMX) in addition to Dex, Smas and Carlos found that the major mechanism by which Dex induces preadipocytes to differentiate into adipocytes is the inhibition of pref-1 expression in preadipocytes [29, 30] and that Dex can independently inhibit pref-1 expression [30] ; that is, Dex has the potential to independently induce stem cells to differentiate into adipocytes.
Sadowski estimated that the expression of more than 100 genes changes during the differentiation of preadipocytes into adipocytes. The most important genes include [31] . In the present study, we chose the early marker of adipogenic differentiation C/EBPα and late stage marker aP2. Dex significantly increased C/EBPα and aP2 expression at the transcriptional and translational levels. A mature adipocyte contains a single large fat droplet surrounded by a thin layer of cytoplasm that lies between the droplet and the plasma membrane [14] . Using oil red staining, we observed that Dex induced some TSCs to differentiate into mature adipocytes. A study from Sona found that the activation of canonical WNT pathway can inhibit C/ EBPα and PPARγ, thereby promoting the differentiation of stem cells into osteoblasts [32] . Wnts act at two points in the adipose development program, early in the program as activators of lineage commitment [33] and late in the program as inhibitors of adipocyte differentiation [14, 32, 34] . Through the inhibition of C/EBPα and PPARγ, the WNT pathway maintains an undifferentiated condition to inhibit the differentiation of preadipocytes into adipocytes [34] . β-Catenin is the pivot molecule of the canonical WNT pathway, β-catenin-dependent signaling has been reported to promote both myogenesis [34] and osteogenesis [35] and to inhibit the differentiation of preadipocytes into adipocytes [33, 36] . In addition, activation of the WNT signaling pathway enhances myogenesis [34] and osteogenesis [28, 37] and inhibits adipogenesis [28] in cultured MSCs. Masako reported that Dex could inhibit the canonical WNT signaling pathway through up regulation of the two inhibitory molecules DKK1 and Axin2 of the canonical WNT signaling pathway, while promoting the degradation of P-GSK-3β, thereby promoting the differentiation of preadipocytes into adipocytes (32, 33) . Studies by Zhang found that Dex could promote TSCs to express PPARγ. In vivo experiments further confirmed the formation of adipose tissue-like entity after the subcutaneous implantation of Dex-treated TSCs. Although PPARγ is frequently used as an adipogenic differentiation marker to examine adipogenic differentiation, our qPCR studies of Dex-treated TSCs showed no statistically significant difference in PPARγ mRNA expression compared with the control group. However, further study is needed to identify the reason. To clarify the mechanism by which Dex suppresses Wnt/β-catenin signaling and promote adipogenesis, the present study examined the expression level of DKK1 in response to Dex stimulation and the effect of DKK1 expression on the adipogenesis of TSCs. Dex promotes the expression of the inhibitory molecule DKK1 of the canonical WNT pathway at the transcriptional and translational levels and down regulates P-GSK-3β (ser9), increases the expression of P-GSK-3β (tyr216), and promotes the degradation of active β-catenin, thereby inhibiting the canonical WNT pathway. Furthermore, DKK1 knockdown or the GSK-3β inhibitor LiCl can attenuate Dex- Fig. 7 . Schematic illustration of the adipogenic differentiation induction of TSCs by Dex through DKK1/GSK-3β/β-catenin. Dex promoted the increase of DKK1 expression, causing downregulation of P-GSK-3β (ser9), up regulation of P-GSK-3β (tyr216), down regulation of β-catenin, and the promotion of adipogenic differentiation of TSCs.
